Pharvaris
PHVS • NASDAQ
Pharvaris is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Berndt Axel Edvard Modig, with a market cap of $1.6B.
CEOBerndt Axel Edvard Modig
Next Earnings
Upcoming earnings announcement for Pharvaris
Date
Monday, April 6, 2026 (in 2 months)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.71
Earnings History
Past 12 earnings reports for Pharvaris
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 2025 | Q3 2025 | -$0.70Est: -$0.78 | +10.3% | - | — | — |
| Aug 12, 2025 | Q2 2025 | -$0.94Est: -$0.87 | -8.0% | - | — | — |
| May 13, 2025 | Q1 2025 | -$0.89Est: -$0.83 | -7.2% | - | — | — |
| Apr 7, 2025 | Q4 2024 | -$0.68Est: -$0.73 | +6.8% | - | — | — |
| Nov 13, 2024 | Q3 2024 | -$0.85Est: -$0.67 | -26.9% | - | — | — |
| Aug 14, 2024 | Q2 2024 | -$0.59Est: -$0.60 | +1.7% | - | — | — |
| May 8, 2024 | Q1 2024 | -$0.56Est: -$0.51 | -9.8% | - | — | — |
| Apr 10, 2024 | Q4 2023 | -$0.80Est: -$0.58 | -37.9% | - | — | — |
| Nov 2, 2023 | Q3 2023 | -$0.63 | — | - | — | — |
| Aug 7, 2023 | Q2 2023 | -$0.69Est: -$0.72 | +4.6% | - | — | — |
| May 8, 2023 | Q1 2023 | -$0.72Est: -$0.83 | +13.3% | - | — | — |
| Apr 5, 2023 | Q4 2022 | -$1.18Est: -$0.58 | -103.4% | - | — | — |